Purchase Order HHSN272201500087P
- Not listed
- This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Revvity Health Sciences, Inc. for $5,308.00 in onsite support services. The contract has a period of performance through August 1, 2015. No set-aside was used for this award. Revvity Health Sciences, Inc. is a for-profit medical imaging company that provides laboratory equipment, maintenance services, and...
- The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a firm-fixed-price purchase order contract to Revvity Health Sciences, Inc., a subsidiary of Revvity Inc., for preventive maintenance of the IVIS-TWINBROOK 3 facility in Bethesda, Maryland. The $19,467.03 contract has an ultimate completion date of November 30, 2012 and does not utilize a set-aside designation. Revvity Health Sciences, Inc. is a for-profit medical imaging...
- This federal contract award is for the purchase of a "TRI-CARB 2100" laboratory instrument and associated services from Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. The $3,066.32 Firm Fixed Price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), a civilian federal agency. The contract does not have a set-aside designation. Revvity Health Sciences provides medical imaging products...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Revvity Health Sciences, Inc. The $3,294.72 firm fixed-price purchase order was for the delivery of a TRICARB 2100 liquid scintillation counter, serial number 424576, with no set-aside designation. Revvity Health Sciences, Inc. is a subsidiary of the parent company Revvity Inc. Medical Imaging Division, which has a history of...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Revvity Health Sciences, Inc. (a subsidiary of Revvity Inc.) for the purchase of a MicroBeta Trilux 6 Detector System. The firm-fixed-price purchase order, valued at $5,737.68, was awarded on December 28, 2010 with a completion date of December 30, 2011. The contract did not have a set-aside designation. Revvity Health Sciences is...
- The U.S. Department of Health and Human Services, National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order for $10,196.68 to Revvity Health Sciences, Inc. for the renewal maintenance agreement on a TriCarb2100 laboratory instrument, serial number 431455. The award had no set-aside designation and the ultimate completion date was December 31, 2011. Revvity Health Sciences, Inc. is a subsidiary of the parent company Revvity Inc., which provides a...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price purchase order contract to Revvity Health Sciences, Inc. for $5,472.00. The contract is for the provision of medical imaging products and services, with a period of performance from September 15, 2017 to September 17, 2018. This contract was not set aside for any small business category. Revvity Health Sciences, Inc. is a for-profit...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. The $4,252.18 firm fixed-price purchase order is for the delivery of laboratory equipment to replace a previous requirement. The award does not have a set-aside designation. Revvity Health Sciences has a history of providing medical imaging products and services, such...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Purchase Order to Revvity Health Sciences, Inc. for a GENE ASSAY SYSTEM 1000ML with a potential value of $13,959.00. The contract has a completion date of September 28, 2018. Revvity Health Sciences, Inc. is a for-profit manufacturer of medical imaging products and services that has received numerous prime contracts and subcontracts from...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. The contract is for the purchase of medical imaging products and services, including automated plate readers, imaging cytometers, liquid scintillation counters, mass spectrometers, and microplate instrumentation, valued at $11,665.44 with a completion date of...
This federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), is to Revvity Health Sciences, Inc. (a subsidiary of Revvity Inc.) for onsite support to remove a radioactive source from TRCARB 3100 equipment. The firm-fixed-price purchase order, valued at $4,527.00, has an ultimate completion date of December 7, 2014. This contract does not have a set-aside designation. Revvity Health Sciences is a for-profit manufacturer and provider of medical imaging products and services to various federal agencies, including the NIH, Centers for Disease Control and Prevention, Department of Defense, and Department of Veterans Affairs. As the parent company, Revvity Inc.'s Medical Imaging division has also received prime contracts and subcontracts to deliver laboratory equipment, maintenance services, and specialized applications to support federal scientific research programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 11/13/14 |